Literature DB >> 2027770

The molecular mechanism of inhibition of alpha-type DNA polymerases by N2-(butylphenyl)dGTP and 2-(butylanilino)dATP: variation in susceptibility to polymerization.

N N Khan1, G E Wright, N C Brown.   

Abstract

Calf thymus DNA polymerase alpha (pol alpha) and bacteriophage T4 DNA polymerase (pol T4) were exploited as model enzymes to investigate the molecular mechanism of inhibitory action of N2-(p-n-butylphenyl)dGTP (BuPdGTP) and 2-(p-n-butyl-anilino)dATP (BuAdATP) on the BuPdNTP-susceptible alpha polymerase family. Kinetic analysis of inhibition of pol alpha with mixtures of complementary and noncomplementary template:primers indicated that both nucleotides induced the formation of a polymerase: inhibitor:primer-template complex. Primer extension experiments using the guanine form as the model analog indicated that pol alpha cannot utilize these nucleotides to extend primer termini. In contrast, pol T4 polymerized BuPdGTP, indicating that resistance to polymerization is not a common feature of the inhibitor mechanism among the broad membership of the alpha polymerase family.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027770      PMCID: PMC333925          DOI: 10.1093/nar/19.7.1627

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Revised nomenclature for eukaryotic DNA polymerases.

Authors:  P M Burgers; R A Bambara; J L Campbell; L M Chang; K M Downey; U Hübscher; M Y Lee; S M Linn; A G So; S Spadari
Journal:  Eur J Biochem       Date:  1990-08-17

2.  Do DNA polymerases delta and alpha act coordinately as leading and lagging strand replicases?

Authors:  F Focher; E Ferrari; S Spadari; U Hübscher
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

3.  An attempt to unify the structure of polymerases.

Authors:  M Delarue; O Poch; N Tordo; D Moras; P Argos
Journal:  Protein Eng       Date:  1990-05

4.  Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.

Authors:  A J Townsend; Y C Cheng
Journal:  Mol Pharmacol       Date:  1987-09       Impact factor: 4.436

5.  Terminal transferase-catalyzed addition of nucleotides to the 3' termini of DNA.

Authors:  R Roychoudhury; R Wu
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex.

Authors:  J E Clements; J D'Ambrosio; N C Brown
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

Review 7.  Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases.

Authors:  G E Wright; N C Brown
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

8.  Primary structure of T4 DNA polymerase. Evolutionary relatedness to eucaryotic and other procaryotic DNA polymerases.

Authors:  E K Spicer; J Rush; C Fung; L J Reha-Krantz; J D Karam; W H Konigsberg
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  Inhibition of a DNA polymerase from Bacillus subtilis by hydroxyphenylazopyrimidines.

Authors:  K B Gass; R L Low; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

Review 10.  Human DNA polymerase alpha: predicted functional domains and relationships with viral DNA polymerases.

Authors:  T S Wang; S W Wong; D Korn
Journal:  FASEB J       Date:  1989-01       Impact factor: 5.191

View more
  2 in total

1.  Chemical and enzymatic incorporation of N2-(p-n-butylphenyl)-2'-deoxyguanosine into an oligodeoxyribonucleotide.

Authors:  H K Misra; N N Khan; S Agrawal; G E Wright
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Analysis of inhibitors of bacteriophage T4 DNA polymerase.

Authors:  N N Khan; L J Reha-Krantz; G E Wright
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.